Source study found
Story checked
Esophageal cancer leaves a distinct metabolic signature in the gut (opens in a new tab)
news-medical.net · 2026-10-01
Short answer
Needs reviewStudy found.
We found the study, but the claim check did not finish.
Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.
Share this check
The story
Esophageal cancer leaves a distinct metabolic signature in the gut
news-medical.net · 2026-10-01
The story’s checkable claims.
Read the original story (opens in a new tab)NewsLink checks it
We found the study behind this story.
We found the study, but couldn't compare the story to it: the study's evidence could not be profiled.
Open claim evidenceThe source study
Fecal metabolomic and microbiome profiling reveals lipid metabolic dysregulation in esophageal cancer
Evidence layer
Claim by claim
The source study was found, but the study's evidence could not be profiled, so these claims couldn't be checked.
Reading mode
Scan verdicts. Open evidence only when needed.
Claim 1 of 5Not checkedResearchers uncovered distinctive gut microbial patterns and hundreds of altered fecal metabolites in people with esophageal cancer, with lipid metabolism standing out as a key signature.View evidenceHide evidence
As statedhundreds of altered fecal metabolites
Not checked
The source study was found, but this claim couldn't be checked against it.
Claim 2 of 5Not checkedA recent Scientific Reports study investigated associations between gut microbiota, fecal metabolic alterations, and esophageal cancer using advanced metabolomic and 16S rRNA gene sequencing approaches.View evidenceHide evidence
Not checked
The source study was found, but this claim couldn't be checked against it.
Claim 3 of 5Not checkedThe study enrolled 34 patients with esophageal cancer and 29 age-, gender-, and diet-matched healthy controls at HuLunBuir People’s Hospital in 2024, and analyzed fecal samples, serum tumor biomarkers, and esophageal tissue.View evidenceHide evidence
As stated34 patients and 29 controls
Not checked
The source study was found, but this claim couldn't be checked against it.
Claim 4 of 5Not checkedMetabolomic profiling revealed 792 differential metabolites, and pathway analysis suggested dysregulation in lipid-related pathways including fatty acid transport, linoleic acid metabolism, glycerolipid metabolism, and PPARA-mediated lipid regulation.View evidenceHide evidence
As stated792 differential metabolites
Not checked
The source study was found, but this claim couldn't be checked against it.
Claim 5 of 5Not checkedThe article says the findings should be interpreted cautiously because the study was retrospective and cross-sectional, the sample was small, many patients had already received anti-tumor treatment, and dietary differences may have influenced the results.View evidenceHide evidence
Not checked
The source study was found, but this claim couldn't be checked against it.
Method layer
NewsLink found the paper. Tessa takes you deeper.
NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.
Open the paper in Tessa
Fecal metabolomic and microbiome profiling reveals lipid metabolic dysregulation in esophageal cancer
Scientific Reports · 2026
Why this one
Near certain
NewsLink found the paper. Tessa is where you inspect it deeply.
Papers considered
The selected paper, plus nearby candidates.
Crossref, PubMed, Europe PMC · 16 candidate papers
Fecal metabolomic and microbiome profiling reveals lipid metabolic dysregulation in esophageal cancer
Scientific Reports · 2026 · Crossref
Bifidobacterium animalis subsp. lactis V9 improves quality of life in advanced gastrointestinal cancer through gut microbiota-metabolite modulation.
ISME Communications · 2026 · PubMed, Europe PMC
Lipid Metabolism Profiling and Bladder Cancer
Journal of Postgenomics Drug & Biomarker Development · 2015 · Crossref
Gut Microbiome-Metabolite Interactions Contribute to Esophageal Cancer Risk: Evidence From Mendelian Randomization and Multiomics Integration.
2026 · Europe PMC
Feasibility of antibiotic-assisted fecal microbiota transplantation with immunotherapy for esophageal and gastric cancer.
Future Oncology (London, England) · 2025 · PubMed
Fiber Type Determines Feline Gut Microbiome Metabolism and Bioactive Lipid Profiles in Feces (P20-034-19)
Current Developments in Nutrition · 2019 · Crossref
And 10 more candidates considered.